Latest accounts payable for 1294.TWO: $100M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Hantech Bio-Technology , Ltd. (1294.TWO) currently reports a accounts payable of $100M as of June 2026. That compares with $85M in the prior-year period — up 17.9% year over year. Use the charts on this page to explore Hantech Bio-Technology , Ltd.'s accounts payable history and peer comparisons.
Hantech Bio-Technology , Ltd.'s accounts payable increased from $85M to $100M — a 17.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Hantech Bio-Technology , Ltd. reported $100M in accounts payable as of June 2026. That compares with $85M in the prior-year period — up 17.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hantech Bio-Technology , Ltd., and consider following 1294.TWO for alerts when major investors trade the stock.